KWM
TMDX icon

Keebeck Wealth Management’s Transmedics TMDX Stock Holding History

Keebeck Wealth Management’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$514K Buy
5,175
+572
+12% +$74.6K 0.06% 230
2025
Q4 		$560K Buy
4,603
+1,768
+62% +$222K 0.06% 203
2025
Q3 		$318K Buy
+2,835
New +$332K 0.04% 294

Other funds holding TMDX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Keebeck Wealth Management's TMDX Position: Q1 2026 in Review

Keebeck Wealth Management increased its Transmedics (TMDX) stake by 12% in Q1 2026, buying an estimated $74.6K and bringing the position to 5,175 shares worth $514K. The position accounts for 0.06% of the portfolio, ranked #230.

Keebeck Wealth Management first reported a position in TMDX in Q3 2025 and has held it in 3 quarters since. The position peaked at $560K in Q4 2025. 414 funds tracked by Wall St. Rank hold TMDX as of Q1 2026.

  • Keebeck Wealth Management held 5,175 shares of Transmedics worth $514K as of Q1 2026.
  • Keebeck Wealth Management bought 572 Transmedics shares in Q1 2026, an estimated $74.6K.
  • Transmedics made up 0.06% of Keebeck Wealth Management's portfolio in Q1 2026, its #230 holding.
  • Keebeck Wealth Management first reported a position in Transmedics in Q3 2025 and has held it in 3 quarters since.
  • Keebeck Wealth Management's Transmedics position peaked at $560K in Q4 2025.
  • 414 funds tracked by Wall St. Rank held Transmedics as of Q1 2026.

Based on Keebeck Wealth Management's 13F filing for Q1 2026, filed 14 May 2026.